期刊文献+

辛伐他汀对人牙周膜细胞成骨活性的影响 被引量:1

Effects of Simvastatin on osteoblast activity of human periodontal ligament cells
下载PDF
导出
摘要 目的研究辛伐他汀对人牙周膜细胞成骨活性的影响。方法将第3代人牙周膜细胞在条件矿化培养液中诱导培养,同时加入不同浓度的辛伐他汀,将其分为A组(0mol/L)、B组(1×10-9mol/L)、C组(1×10-8mol/L)、D组(1×10-7mol/L)、E组(1×10-6mol/L),分别检测碱性磷酸酶活性、骨桥蛋白(OPN)表达,并对矿化结节进行计数。结果辛伐他汀各浓度组(1×10-9、1×10-8、1×10-7、1×10-6mol/L)均能促进人牙周膜细胞的成骨分化和矿化,其中1×10-8、1×10-7、1×10-6mol/L与对照组比较,差异有统计学意义(P<0.05),1×10-7mol/L的辛伐他汀组促进成骨活性的作用最明显。结论适宜浓度的辛伐他汀可以有效促进人牙周膜细胞的成骨活性。 Objective To study the effects of Simvastatin on the osteoblast activity of human periodontal ligament (PDL) cells. Methods The third passage human PDL were cultured in conditional mineralization medium with different concentrations of Simvastatin. The cells were divided into A group(0mol/L), B group(1×10^-9mol/L), C group (1×10^-8mol/L), D group(1×10^-7mol/L) and E group(1×10^-6mol/L). Alkaline phosphatase(ALP) activity, osteopontin (OPN) and capability of mineralization were measured. Results Differentiation osteoblast and mineralization of human PDL were improved in all treatment groups with different concentrations of Simvastatin(1×10^-9, 1×10^-8, 1×10^-7, 1×10^-6mol/L). Compared with control group, statistically significant differences were found in 1×10^-8mol/L, 1×10^-7mol/L and 1×10^-6 mol/L groups(P〈0.05). The maximum effect was observed at the concentration of 1×10^-7 mol/L. Conclusion Optimal concentration of Simvastatin can improve the osteoblastic activity of human PDL.
出处 《华西口腔医学杂志》 CAS CSCD 北大核心 2009年第3期313-316,共4页 West China Journal of Stomatology
基金 国家"十五"科技计划攻关课题资助项目(2007BAI18B-O6) 广东省科技三项经费计划资助项目(2006B19901006) 广东省医学科学研究基金资助项目(A2007102)
关键词 辛伐他汀 牙周膜细胞 成骨活性 Simvastatin periodontal ligament cells osteoblast activity
  • 相关文献

参考文献9

  • 1Mundy G, Garrett R, Harris S. Stimulation of bone formation in vitro and in rodents by statins[J]. Science, 1999, 286(5446): 1946-1949.
  • 2Hwang R, Lee EJ, Kim MH. Calcyclin, a Ca^2+ ion-binding protein, contributes to the anabolic effects of simvastatin on bone[J]. J Biol Chem, 2004, 279(20):21239-21247.
  • 3Sugiyama M, Kodama T, Konishi K. Compactin and simvastatin, but not pravastatin, induce bone morphogenetie protein-2 in human osteosarcoma cells[J]. Biochem Biophys Res Commun, 2000, 271 (3) : 688-692.
  • 4Wang PS, Solomon DH, Mogun H, et al. HMG-CoA reduetase inhibitors and the risk of hip fractures in elderly patients[J]. JAMA, 2000, 283 (24) : 3211-3216.
  • 5Chan KA, Andrade SE, Boles M, et al. Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women[J]. Lancet, 2000, 355 (9222) : 2185-2188.
  • 6Maeda T, Matsunuma A, Kawane T, et al. Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells [J]. Biochem Biophys Res Commun, 2001, 280(3):874-877.
  • 7吴莉萍,凌均棨.牙周膜维持结构和功能稳定的分子机制[J].国际口腔医学杂志,2007,34(2):87-89. 被引量:1
  • 8Bosshardt DD, Zalzal S, McKee MD, et al. Developmental appearance and distribution of bone sialoprotein and osteopontin in human and rat cementum[J]. Anat Rec, 1998, 250(1): 13-33.
  • 9Yamamoto T, Demon T, Takahashi S, et al. Immunoloeation of proteoglycans and bone-related noncollagenous glyeoproteins in developing aeellular cementum of rat molars[J]. Cell Tissue Res, 2004, 317(3) :299-312.

二级参考文献24

  • 1[1]Nemcovsky CE,Bony L,Shanberger S,et al.J Periodontol,2004,75 (7).1013-1019.
  • 2[2]Isaka J,Ohazama A,Kobayashi M,et al.J Periodontol,2001,72(3):314-323.
  • 3[3]Nemoto E,Shimonishi M,Nitta Y,et al.J Periodontal Res,2004,39(6):388-397.
  • 4[4]Ito-Kato E,Suzuki N,Maeno M,et al.J Periodontol,2004,39 (3):199-204.
  • 5[5]Yamaguchi N,Chiba M,Mitani H.Arch Oral Biol,2002,47 (6):465-471.
  • 6[6]Seo BM,Miura M,Gronthos S,et al.Lancet,2004,364(10):149-155.
  • 7[7]Trubiani O,Primio DR,Traini T.Int J Immunopathol Pharmacol,2005,18(2):213-221.
  • 8[8]Kato C,Kojima T,Komaki M,et al.Biochem Biophys Res Commun,2005,326(1):147-153.
  • 9[9]Ohno S,Doi T,Fujimoto K.J Dent Res,2002,81 (12):822-825.
  • 10[10]Dio S,Ohno K,Tanimoto K,et al.Arch Oral Biol,2003,48 (4):573-579.

同被引文献18

  • 1杨雪超,樊明文.成体人牙髓干细胞的分离与鉴定[J].中华口腔医学杂志,2005,40(3):244-247. 被引量:22
  • 2Ahn KS,Sethi G,Chaturvedi MM,et al.Simvastatin, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, suppresses osteoclastogenesis induced by receptor activator of nuclear fator-kappaB ligand through modulation of NK-kappaB pathway [J].Int J Cancer,2008,123 (8): 1733-1740.
  • 3Plosker GL,McTavish D.Simvastatin:a reappraisal of its pharmacology and therapeutic efficacy in hypercholesterolaemia[J].Drugs, 1995,50:334-363.
  • 4Mundy G,Garrett R,Harris S,et al.Stimulation of bone formation in vitro and in rodents by statins [J].Science, 1999,286,1946-1949.
  • 5Okamoto Y,Sonoyama W, Ono M,et al.Simvastatin induces the odontogenic differentiation of human dental pulp stem cells in vitro and in vivo[J].J Endod,2009,35(3): 367-372.
  • 6Gronthos S,Brahim J,Li W, et al.Stem cell properties of human dental pulp stem cells [J].J Dent Res,2002,81 (8): 531-535.
  • 7Ryusuke Nakatsuka,Tadashige Nozaki,Yasushi Uemura,et al.5-Aza-2' -deoxycytidine treatment induces skeletal myogenic differentiation of mouse dental pulp stem cells [J]. Oral biology,2010,55(5):350-357.
  • 8D' Alimonte I, Nargi E,Mastrangelo F, et al. Vascular endothelial growth factor enhances in vitro proliferation and osteogenic differentiation of human dental pulp stem cells[J]. J Biol Regul Homeost Agents,2011,25(1): 57-69.
  • 9Karbanova J,Soukup T,Suchanek J,et al.Osteogenic differentiation of human dental pulp-derived stem cells under various ex-vivo culture conditions [J]. Acta Medica (Hradec Kralove),2010,53(2):79-84.
  • 10Laino G,d' Aquino R, Graziano A,et al.A new population of human adult dental pulp stem cells: a useful source of living autologous fibrous bone tissue(LAB)[J].J Bone Miner Res,2005,20(8): 1394-1402.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部